Medico-social efficiency of pneumococcal vaccine in patients with chronic obstructive lung disease

Abstract

The author provides data about introduction of vaccine ‘Pneumo-23’ in 98 patients with chronic obstructive lung disease of varying severity. The efficiency of vaccination has been estimated based upon the dynamics of medico-social indices. During 12 months, the mean quantity and duration of hospitalisation in case of chronic obstructive lung disease of mild and moderate severity considerably decreased. As stated, there was a reliable decrease in a number of cases and days of temporary disability among the patients with the mild course of the chronic obstructive lung disease. The persistent loss of occupational capacity remained relatively stable while it increased by 25% in the non-vaccinated group (the control group comprised of 20 patients). The findings allowed to recommend applying pneumococcal vaccine as a part of integrated treatment of mild and moderate chronic obstructive lung disease.